Quality of Life and Cost-Effectiveness 1 Year After Total Hip Arthroplasty

Journal of Arthroplasty

Volumn 26, Issue 5, 2011, Pages 705-709

  Lavernia, Carlos J ^a,b   Alcerro, Jose C ^b  

^a Mercy Hospital Miami   (United States)

^b Arthritis Surgery and Research Foundation   (United States)

Author keywords

Cost effectiveness; Primary hip arthroplasty; Quality of life; Revision hip arthroplasty

Indexed keywords

ABLATION THERAPY; ARTICLE; CALCULATION; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; STOMACH BYPASS; TOTAL HIP PROSTHESIS;

AGE FACTORS; ARTHROPLASTY, REPLACEMENT, HIP; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OSTEOARTHRITIS, HIP; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79960449570     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2010.07.026     Document Type: Article

References (39)

1. Sisko A., Truffer C., Smith S., et al. Health spending projections through 2018: recession effects add uncertainty to the outlook. Health Aff (Millwood) 2009, 28:w346.
2. Bitton R. The economic burden of osteoarthritis. Am J Manag Care 2009, 15(8 Suppl):S230.
3. Binder J.R. Will reimbursement policies create an access crisis?. AAOS Now 2008, 2:70.
4. Scott W.N., Booth R.E., Dalury D.F., et al. Efficiency and economics in joint arthroplasty. J Bone Joint Surg Am 2009, 91(Suppl 5):33.
5. Liang M.H., Cullen K.E., Larson M.G., et al. Cost-effectiveness of total joint arthroplasty in osteoarthritis. Arthritis Rheum 1986, 29:937.
6. Mushlin A.I., Fintor L. Is screening for breast cancer cost-effective?. Cancer 1992, 69(7 Suppl):1957.
7. Wu S.Y., Sainfort F., Tomar R.H., et al. Development and application of a model to estimate the impact of type 1 diabetes on health-related quality of life. Diabetes Care 1998, 21:725.
8. Lavernia C.J., Guzman J.F., Gachupin-Garcia A. Cost-effectiveness and quality of life in knee arthroplasty. Clin Orthop Relat Res 1997, 134.
9. Kaplan R.M.B.J.W. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol 1982, 1:61.
10. Munzenberger P.J., Van Wagnen C.A., Abdulhamid I., et al. Quality of life as a treatment outcome in patients with cystic fibrosis. Pharmacotherapy 1999, 19:393.
11. Kotwicki R.J., Condra L., Vermeulen L., et al. Assessing the quality of life in children with cystic fibrosis. WMJ 2001, 100:50.
12. Aguiar C.C., Vieira A.P., Carvalho A.F., et al. Assessment instruments for a Health-Related Quality of Life in diabetes mellitus. Arq Bras Endocrinol Metabol 2008, 52:931.
13. Holbrook T.L., Hoyt D.B., Stein M.B., et al. Gender differences in long-term posttraumatic stress disorder outcomes after major trauma: women are at higher risk of adverse outcomes than men. J Trauma 2002, 53:882.
14. Kaplan R.M., Alcaraz J.E., Anderson J.P., et al. Quality-adjusted life years lost to arthritis: effects of gender, race, and social class. Arthritis Care Res 1996, 9:473.
15. Gill T.M., Feinstein A.R. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994, 272:619.
16. Barton G.R., Sach T.H., Jenkinson C., et al. Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?. Health Qual Life Outcomes 2008, 6:51.
17. O'Brien B.J., Spath M., Blackhouse G., et al. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ 2003, 12:975.
18. Kaplan R.M., Ganiats T.G., Sieber W.J., et al. The Quality of Well-Being Scale: critical similarities and differences with SF-36. Int J Qual Health Care 1998, 10:509.
19. Kinosian B.P., Eisenberg J.M. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia. JAMA 1988, 259:2249.
20. Angus D.C., Musthafa A.A., Clermont G., et al. Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001, 163:1389.
21. Patrick D.L., Ramsey S.D., Spencer A.C., et al. Economic evaluation of aquatic exercise for persons with osteoarthritis. Med Care 2001, 39:413.
22. Laupacis A., Bourne R., Rorabeck C., et al. Costs of elective total hip arthroplasty during the first year. Cemented versus noncemented. J Arthroplasty 1994, 9:481.
23. Rasanen P., Paavolainen P., Sintonen H., et al. Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthop 2007, 78:108.
24. Strauss J.B., Chen S.S., Shah A.P., et al. Cost of radiotherapy versus NSAID administration for prevention of heterotopic ossification after total hip arthroplasty. Int J Radiat Oncol Biol Phys 2008, 71:1460.
25. Mahadeva S., Chia Y.C., Vinothini A., et al. Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia. Gut 2008, 57:1214.
26. Niemczyk M., Nowak M., Pilecki T., et al. Economic evaluation of sirolimus-based immunosuppressive regimens in kidney graft recipients. Transplant Proc 2006, 38:74.
27. Picot M.C., Neveu D., Kahane P., et al. Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy-preliminary results. Rev Neurol (Paris) 2004, 160(Spec No 1):5S354.
28. Gasior M., Gierlotka M., Gasior U., et al. Cost-effectiveness of coronary angioplasty procedures in Poland. Kardiol Pol 2004, 61:42. discussion 48.
29. McGarry L.J., Thompson D., Weinstein M.C., et al. Cost-effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Am J Manag Care 2004, 10:632.
30. Brosa Riestra M., Rubio-Terres C., Nadipelli V., et al. Cost-effectiveness analysis of enoxaparin for the prophylaxis of venous thromboembolism in major orthopedic surgery patients. Farm Hosp 2003, 27:210.
31. Nasuti J.F., Gupta P.K., Baloch Z.W. Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases. Diagn Cytopathol 2002, 27:1.
32. Kaplan R.M, Bush J.W. Health-related quality of life measurements for evaluation research and policy analysis. Health Psychol 1981, 1:61.
33. Chang R.W., Pellisier J.M., Hazen G.B. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 1996, 275:858.
34. King J.T., Sperling M.R., Justice A.C., et al. A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy. J Neurosurg 1997, 87:20.
35. Langfitt J.T. Cost-effectiveness of anterotemporal lobectomy in medically intractable complex partial epilepsy. Epilepsia 1997, 38:154.
36. Craig B.M., Tseng D.S. Cost-effectiveness of gastric bypass for severe obesity. Am J Med 2002, 113:491.
37. Huo M.H., Parvizi J., Bal B.S., et al. What's new in total hip arthroplasty. J Bone Joint Surg Am 2009, 91:2522.
38. Swiontkowski M.F., Chapman J.R. Cost and effectiveness issues in care of injured patients. Clin Orthop Relat Res 1995, 17.
39. Gonzalez-Perez J.G., Vale L., Stearns S.C., et al. Hemodialysis for end-stage renal disease: a cost-effectiveness analysis of treatment-options. Int J Technol Assess Health Care 2005, 21:32.